Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / June / AI Model Predicts Cancer Treatment Response
Oncology Bioinformatics Precision medicine Omics Clinical care Molecular Pathology Research and Innovations

AI Model Predicts Cancer Treatment Response

Complex genetic mutation patterns are linked with immunotherapy and chemotherapy outcomes

06/16/2026 News 3 min read
  • Full Article
  • Summary
  • Listen
  • Report
  • Quiz
  • Top Institutions

Share

Top Institutions in Oncology

Ranking is based on citation frequency across our internal corpus of peer-reviewed articles.

  • #1

    Dana-Farber Cancer Institute

    Boston, MA

    Dana-Farber is a leader in cancer research, particularly at the intersection of clinical oncology and artificial intelligence. Their work aims to develop practical tools to enhance patient care.

    Key Differentiators

    • Oncology
  • #2

    University of California San Diego

    La Jolla, CA

    UC San Diego is recognized for its innovative research in AI applications for cancer treatment. Their AI model is designed to predict tumor responses effectively.

    Key Differentiators

    • Oncology
  • #3

    National Cancer Institute

    Bethesda, MD

    The National Cancer Institute is at the forefront of cancer research and has developed an AI model that leverages individual tumor cell data to predict drug responses.

    Key Differentiators

    • Oncology
  • #4

    University of Chicago Medical Center

    Chicago, IL

    The University of Chicago Medical Center contributes valuable data through its independent patient cohorts, enhancing the validation of AI models in oncology.

    Key Differentiators

    • Oncology

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

A Helping Hand from AI in Prostate Cancer Diagnostics
Precision medicine
A Helping Hand from AI in Prostate Cancer Diagnostics

February 8, 2022

3 min read

Using AI to enhance personalized healthcare for patients with prostate cancer

The Ultimate Vision for Rare Disease
Precision medicine
The Ultimate Vision for Rare Disease

February 28, 2022

1 min read

Genomics and computational pathology can take rare disease diagnostics to the next level

A Light in the Darkness
Precision medicine
A Light in the Darkness

March 4, 2022

2 min read

Spectroscopic liquid biopsy testing – a new route to brain cancer diagnostics

In-House Matters
Precision medicine
In-House Matters

April 7, 2022

3 min read

Molecular pathology is complex – and the benefits of keeping it local are extensive

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.